MedPath

Anesthetic Efficacy of 1.8 ml Versus 3.6 ml of 4% Articaine Buccal Infiltration

Not Applicable
Not yet recruiting
Conditions
Symptomatic Irreversible Pulpitis
Interventions
Drug: 1.8 ml 4% Articaine hydrochloride
Drug: 3.6 ml 4% Articaine hydrochloride
Registration Number
NCT06119139
Lead Sponsor
Cairo University
Brief Summary

The aim of the study is to compare the anesthetic efficacy and need for supplemental anesthesia of 1.8 ml compared to 3.6 ml of 4% articaine buccal infiltration in mandibular molars with symptomatic irreversible pulpitis.

Detailed Description

Patients with moderate-to-severe pain due to symptomatic irreversible pulpitis will be included. Patients will be randomly assigned into two groups to receive either 1.8 ml 4% articaine buccal infiltration or 3.6. ml 4% articaine buccal infiltration before single visit root canal treatments. Intraoperative pain will be assessed using an 11-point numerical rating scale (NRS) so that anesthetic success will be defined as no to mild intraoperative pain. The need for supplemental anesthesia will also be recorded.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
70
Inclusion Criteria
  1. Healthy patients who are categorized as I or II according to The American Society of Anesthesiologists (ASA class I or II).
  2. No sex predilection
  3. Patients with symptomatic irreversible pulpitis
  4. Patient with the ability to understand and use pain scales.
  5. Patients who accept to enroll in the study.
Read More
Exclusion Criteria
  1. Patients' allergies to any of the drugs or materials used in the study.
  2. Pregnant and lactating females.
  3. Patients taking analgesics in the last 6-8 hours.
  4. Patients having more than one symptomatic tooth in the same quadrant
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1.8 ml 4% articaine buccal infiltration.1.8 ml 4% Articaine hydrochloride-
3.6 ml 4% articaine buccal infiltration3.6 ml 4% Articaine hydrochloride-
Primary Outcome Measures
NameTimeMethod
Anesthetic successDuring the procedure

Will be measured by 11-point numerical rating scale NRS. The success will be defined as no or mild pain (NRS 0 or less than 3) and the failure will be defined as moderate to severe pain (NRS more than 3).

Secondary Outcome Measures
NameTimeMethod
Need for supplemental anesthesiaDuring the procedure

Whether the patient requires supplemental anesthesia or not. It will be recorded by the questionnaire (yes or no).

© Copyright 2025. All Rights Reserved by MedPath